Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.
about
Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity.Relevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer.Patient-derived xenograft (PDX) models in basic and translational breast cancer research.The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring.Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis.Tumor Uptake of 64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer.Future Clinical Trials: Genetically Driven Trials.Frequency of breast cancer subtypes among African American women in the AMBER consortium.Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective.Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options.Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer.Intra-individual Gene Expression Variability of Histologically Normal Breast Tissue.
P2860
Q37684647-E678CB3E-7D28-4F3D-A851-E22C52EF93F8Q37737882-386809EA-332D-491D-921E-FAC7422FFD3AQ39057246-1CE3D5A6-6D9D-4A56-9F5B-F4BF15CDC2E9Q39183864-C0895CFB-633A-4EE9-86BC-0D6D0A9FE3BEQ47140684-39F3DB97-5516-4162-A2C5-63EB26E1054EQ47279118-377640CA-E166-4B68-96BC-966286EF6054Q47573583-FF93AD7A-1818-4E59-8494-CED00F0D76C4Q47942762-CD8B5F76-1CCD-4357-B25F-444E8AC84040Q48499819-9980AEC6-8663-4A8C-9F8E-0E5B3904A1ACQ48521971-9A2D5423-F7C8-48BA-B26C-075B5548741BQ49796316-A87E6DFE-BF90-40A5-9628-B44B152D66ABQ55070669-58DC096C-CB9B-4050-AF4A-B195F4B03647Q55407111-E1466988-7840-4734-A660-7F6071BF51C6
P2860
Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intratumoral heterogeneity as ...... ncer biomarker classification.
@en
Intratumoral heterogeneity as ...... ncer biomarker classification.
@nl
type
label
Intratumoral heterogeneity as ...... ncer biomarker classification.
@en
Intratumoral heterogeneity as ...... ncer biomarker classification.
@nl
prefLabel
Intratumoral heterogeneity as ...... ncer biomarker classification.
@en
Intratumoral heterogeneity as ...... ncer biomarker classification.
@nl
P2093
P2860
P1476
Intratumoral heterogeneity as ...... ncer biomarker classification.
@en
P2093
Andrew F Olshan
Emma H Allott
Gary R Zirpoli
Joseph Geradts
Julie R Palmer
Mark E Sherman
Melissa A Troester
Mengjie Chen
Stephanie M Cohen
Thaer Khoury
P2860
P2888
P356
10.1186/S13058-016-0725-1
P577
2016-06-28T00:00:00Z
P6179
1053696936